Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer

• SOGA Norihito

  Division of Nephro-Urologic Surgery and Andrology, Department of Reparative and Regenerative Medicine, Institute of Medical Life Science, Mie University Graduate School of Medicine

• KISE Hideaki

  Division of Nephro-Urologic Surgery and Andrology, Department of Reparative and Regenerative Medicine, Institute of Medical Life Science, Mie University Graduate School of Medicine

• ARIMA Kiminobu

  Division of Nephro-Urologic Surgery and Andrology, Department of Reparative and Regenerative Medicine, Institute of Medical Life Science, Mie University Graduate School of Medicine

• SUGIMURA Yoshiki

  Division of Nephro-Urologic Surgery and Andrology, Department of Reparative and Regenerative Medicine, Institute of Medical Life Science, Mie University Graduate School of Medicine

収録刊行物

• International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology

  International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology 15 (4), 376-381, 2010-08-01

キーワード

• Gemcitabine
• Platinum-resistant urothelial cancer

詳細情報

• CRID: 1571980075914436352
• NII論文ID: 10026601385
• NII書誌ID: AA11086579
• ISSN: 13419625
• Web Site: https://search.jamas.or.jp/link/ui/2011065068
• 本文言語コード: en
• データソース種別:
  • CiNii Articles